File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Peptidoglycan-induced IL-6 production in RAW 264.7 macrophages is mediated by cyclooxygenase-2, PGE2/PGE4 receptors, protein kinase A, IκB kinase, and NF-κB

TitlePeptidoglycan-induced IL-6 production in RAW 264.7 macrophages is mediated by cyclooxygenase-2, PGE<inf>2</inf>/PGE<inf>4</inf> receptors, protein kinase A, IκB kinase, and NF-κB
Authors
Issue Date2006
Citation
Journal of Immunology, 2006, v. 177, n. 1, p. 681-693 How to Cite?
AbstractIn this study, we investigated the signaling pathway involved in IL-6 production caused by peptidoglycan (PGN), a cell wall component of the Gram-positive bacterium, Staphylococcus aureus, in RAW 264.7 macrophages. PGN caused concentration- and time-dependent increases in IL-6, PGE2, and cAMP production. PGN-mediated IL-6 production was inhibited by a nonselective cyclooxygenase (COX) inhibitor (indomethacin), a selective COX-2 inhibitor (NS398), a PGE2 (EP2) antagonist (AH6809), a PGE4 (EP4) antagonist (AH23848), and a protein kinase A (PKA) inhibitor (KT5720), but not by a nonselective NO synthase inhibitor (NG-nitro-L-arginine methyl ester). Furthermore, PGE2, an EP2 agonist (butaprost), an EP2/PGE3 (EP3)/EP4 agonist (misoprostol), and misoprostol in the presence of AH6809 all induced IL-6 production, whereas an EP1/EP3 agonist (sulprostone) did not. PGN caused time-dependent activations of IκB kinase αβ (IKKdβ) and p65 phosphoryiation at Ser276, and these effects were inhibited by NS398 and KT5720. Both PGE2 and 8-bromo-cAMP also caused IKKdβ kinase αβ phosphorylation. PGN resulted in two waves of the formation of NF-κB-specific DNA-protein complexes. The first wave of NF-κB activation occurred at 10-60 min of treatment, whereas the later wave occurred at 2-12 h of treatment. The PGN-induced increase in κB luciferase activity was inhibited by NS398, AH6809, AH23848, KT5720, a protein kinase C inhibitor (Ro31-8220), and a p38 MAPK inhibitor (SB203580). These results suggest that PGN-induced IL-6 production involves COX-2-generated PGE2, activation of the EP2 and EP4 receptors, cAMP formation, and the activation of PKA, protein kinase C, p38 MAPK, IKKdβ, kinase αβ, p65 phosphorylation, and NF-κB. However, PGN-induced NO release is not involved in the signaling pathway of PGN-induced DL-6 production. Copyright © 2006 by The American Association of Immunologists, Inc.
Persistent Identifierhttp://hdl.handle.net/10722/241138
ISSN
2023 Impact Factor: 3.6
2023 SCImago Journal Rankings: 1.558
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorChen, Bing Chang-
dc.contributor.authorLiao, Chiao Chun-
dc.contributor.authorHsu, Ming Jen-
dc.contributor.authorLiao, Yi Ting-
dc.contributor.authorLin, Chia Chin-
dc.contributor.authorSheu, Joen Rong-
dc.contributor.authorLin, Chien Huang-
dc.date.accessioned2017-05-26T03:36:55Z-
dc.date.available2017-05-26T03:36:55Z-
dc.date.issued2006-
dc.identifier.citationJournal of Immunology, 2006, v. 177, n. 1, p. 681-693-
dc.identifier.issn0022-1767-
dc.identifier.urihttp://hdl.handle.net/10722/241138-
dc.description.abstractIn this study, we investigated the signaling pathway involved in IL-6 production caused by peptidoglycan (PGN), a cell wall component of the Gram-positive bacterium, Staphylococcus aureus, in RAW 264.7 macrophages. PGN caused concentration- and time-dependent increases in IL-6, PGE2, and cAMP production. PGN-mediated IL-6 production was inhibited by a nonselective cyclooxygenase (COX) inhibitor (indomethacin), a selective COX-2 inhibitor (NS398), a PGE2 (EP2) antagonist (AH6809), a PGE4 (EP4) antagonist (AH23848), and a protein kinase A (PKA) inhibitor (KT5720), but not by a nonselective NO synthase inhibitor (NG-nitro-L-arginine methyl ester). Furthermore, PGE2, an EP2 agonist (butaprost), an EP2/PGE3 (EP3)/EP4 agonist (misoprostol), and misoprostol in the presence of AH6809 all induced IL-6 production, whereas an EP1/EP3 agonist (sulprostone) did not. PGN caused time-dependent activations of IκB kinase αβ (IKKdβ) and p65 phosphoryiation at Ser276, and these effects were inhibited by NS398 and KT5720. Both PGE2 and 8-bromo-cAMP also caused IKKdβ kinase αβ phosphorylation. PGN resulted in two waves of the formation of NF-κB-specific DNA-protein complexes. The first wave of NF-κB activation occurred at 10-60 min of treatment, whereas the later wave occurred at 2-12 h of treatment. The PGN-induced increase in κB luciferase activity was inhibited by NS398, AH6809, AH23848, KT5720, a protein kinase C inhibitor (Ro31-8220), and a p38 MAPK inhibitor (SB203580). These results suggest that PGN-induced IL-6 production involves COX-2-generated PGE2, activation of the EP2 and EP4 receptors, cAMP formation, and the activation of PKA, protein kinase C, p38 MAPK, IKKdβ, kinase αβ, p65 phosphorylation, and NF-κB. However, PGN-induced NO release is not involved in the signaling pathway of PGN-induced DL-6 production. Copyright © 2006 by The American Association of Immunologists, Inc.-
dc.languageeng-
dc.relation.ispartofJournal of Immunology-
dc.titlePeptidoglycan-induced IL-6 production in RAW 264.7 macrophages is mediated by cyclooxygenase-2, PGE<inf>2</inf>/PGE<inf>4</inf> receptors, protein kinase A, IκB kinase, and NF-κB-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.pmid16785567-
dc.identifier.scopuseid_2-s2.0-33745317580-
dc.identifier.volume177-
dc.identifier.issue1-
dc.identifier.spage681-
dc.identifier.epage693-
dc.identifier.isiWOS:000238471400080-
dc.identifier.issnl0022-1767-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats